Contravisory Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Contravisory Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	+2,430	New	+$249K	0.04%	206

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Contravisory Investment Management's LMAT Position: Q2 2026 in Review

Contravisory Investment Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 2,430 shares worth $233K. The stake represents 0.04% of the portfolio and ranks #206 among its holdings.

327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Contravisory Investment Management held 2,430 shares of LeMaitre Vascular worth $233K as of Q2 2026.
LeMaitre Vascular was a new Contravisory Investment Management position in Q2 2026.
LeMaitre Vascular made up 0.04% of Contravisory Investment Management's portfolio in Q2 2026, its #206 holding.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.